Table 3. Change in Clinical Measures from Before to After the Program for the Entire Patient Sample and Patients Above Clinical Practice Guideline (CPG) Targets*
Patient SamplesPatients (n)Before the ProgramAfter the ProgramP Value
Entire patient sample
    Mean A1c, % (SD)8167.2 (0.01)7.3 (0.01)<.01†
    Patients at A1c target (%)*81655.053.6.379
    Mean systolic BP, mmHg (SD)915133.7 (15.8)131.4 (16.0)<.001‡
    Mean diastolic BP, mmHg (SD)91573.7 (10.1)72.5 (9.7)<.01‡
    Patients at BP target (%)*91540.850.7<.001‡
    Mean LDL, mmol/L (SD)5972.4 (0.9)2.2 (0.9)<.001‡
    Patients at LDL target (%)*59738.248.7<.001‡
Patients above CPG targets* before the program
    Mean A1c, % (SD)3678.2 (0.01)8.0 (0.01)<.01‡
    Mean systolic BP, mmHg (SD)542143.0 (12.4)134.4 (15.6)<.001‡
    Mean diastolic BP, mmHg (SD)54277.1 (9.9)73.6 (9.8)<.001‡
    Mean LDL, mmol/L (SD)3692.9 (0.8)2.5 (0.9)<.001‡

  • ↵* CPG targets are glycosylated hemoglobin (A1C) (>7%), low-density lipoprotein (LDL) (>2.0 mmol/L), or blood pressure (BP) (>130/80 mm Hg).

  • ↵† Significant change in a negative direction.

  • ↵‡ Statistically significant at P < .05.

  • SD, standard deviation.